AIMS Medical Science, 2017, 4(2): 217-232. doi: 10.3934/medsci.2017.2.217

Research article

Export file:

Format

  • RIS(for EndNote,Reference Manager,ProCite)
  • BibTex
  • Text

Content

  • Citation Only
  • Citation and Abstract

Impact of A Waning Vaccine and Altered Behavior on the Spread of Influenza

1 Department of Mathematics and Computational Science, University of South Carolina Beaufort, Bluffton, South Carolina, USA;
2 Department of Natural Sciences, University of South Carolina Beaufort, Bluffton, South Carolina, USA;
3 Michigan State University College of Osteopathic Medicine, East Lansing, Michigan, USA;
4 Department of Mathematics and Statistics, Washington State University, Pullman, Washington, USA;
5 School of Biological Sciences, Washington State University, Pullman, Washington, USA;
6 Analytics, Intelligence, and Technology Division, Los Alamos National Laboratory, Los Alamos, New Mexico, USA

Influenza remains one of the major infectious diseases that targets humankind. Understanding within-host dynamics of the virus and how it translates into the spread of the disease at a population level can help us obtain more accurate disease outbreak predictions. We created an ordinary differential equation model with parameter estimates based on the disease symptoms score data to determine various disease stages and parameters associated with infectiousness and disease progression. Having various stages with different intensities of symptoms enables us to incorporate spontaneous behavior change due to the onset/offset of disease symptoms. Additionally, we incorporate the effect of a waning vaccine on delaying the time and decreasing the size of an epidemic peak. Our results showed that the epidemic peak in the model was significantly lowered when public vaccination was performed up to two months past the onset of an epidemic. Also, behavior change in the earliest stages of the epidemic lowers and delays the epidemic peak. This study further provides information on the potential impact of pharmaceutical and non-pharmaceutical interventions during an influenza epidemic.
  Figure/Table
  Supplementary
  Article Metrics

References

1. WHO (2014) Influenza (Seasonal) [Web]. World Health Organization. Available from: http://www.who.int/mediacentre/factsheets/fs211/en/.

2. CDC (2010) Estimates of Deaths Associated with Seasonal Influenza --- United States, 1976-2007. 2010 Aug 27. MMWR 59(33);1057-1062.

3. CDC (2016) Overview of Influenza Surveillance in the United States. CDC Available from: http://www.cdc.gov/flu/weekly/overview.htm.

4. WHO (2016) Global Influenza Surveillance and Response System (GISRS). Available from: http://www.who.int/influenza/gisrs_laboratory/en/.

5. WHO (2016) Vaccines [Web]. Available from: http://www.who.int/influenza/vaccines/en/.

6. Ferdinands JM, Fry AM, Reynolds S, et al. (2016) Intraseason waning of influenza vaccine protection: Evidence from the US Influenza Vaccine Effectiveness Network, 2011-12 through 2014-15. Clin Infect Dis: pii: ciw816.

7. CDC (2017) Influenza (Flu) [Web]. CDC [updated March 10, 2017; cited 2017]. Available from: https://www.cdc.gov/flu/index.htm.

8. Wong SS, Webby RJ (2013) Traditional and new influenza vaccines. Clin Microbiol Rev 26: 476-492.    

9. Belshe RB, Mendelman PM, Treanor J, et al. (1998) The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. N Engl J Med 338: 1405-1412.    

10. Talbot HK, Zhu Y, Chen Q, et al. (2013) Effectiveness of influenza vaccine for preventing laboratory-confirmed influenza hospitalizations in adults, 2011-2012 influenza season. Clin Infect Dis 56:1774-1777.    

11. Lisa A, Grohskopf LZS, Sonja J. Olsen, et al. (2015) Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2015–16 Influenza Season. 2015 Aug 7, MMWR Vol. 64;No. 30.

12. Cowling BJ, Chan KH, Fang VJ, et al. (2009) Facemasks and hand hygiene to prevent influenza transmission in households: a cluster randomized trial. Ann Intern Med 151: 437-446.    

13. Aiello AE, Murray GF, Perez V, et al. (2010) Mask use, hand hygiene, and seasonal influenza-like illness among young adults: a randomized intervention trial. J Infect Di s 201:491-498.

14. Chowell G, Viboud C, Wang X, et al. (2009) Adaptive vaccination strategies to mitigate pandemic influenza: Mexico as a case study. PLoS currents 1: RRN1004.

15. Feng Z, Towers S, Yang Y (2011) Modeling the effects of vaccination and treatment on pandemic influenza. AAPS J Sep 13: 427-437.    

16. Larson RC, Teytelman A (2012) Modeling the effects of H1N1 influenza vaccine distribution in the United States. Value Health 15: 158-166.    

17. Poletti P, Caprile B, Ajelli M, et al. (2009) Spontaneous behavioural changes in response to epidemics. J Theor Biol 260: 31-40.    

18. Pawelek KA, Salmeron C, Valle SD (2015) Connecting Within and Between-hosts Dynamics in the Influenza Infection-staged Epidemiological Models with Behavior Change. J Coupled Syst Multiscale Dyn 3: 233-243.    

19. Diekmann O, Heesterbeek JA, Metz JA (1990) On the definition and the computation of the basic reproduction ratio R0 in models for infectious diseases in heterogeneous populations. J Math Biol 28:365-382.

20. Lord CC, Woolhouse ME, Heesterbeek JA, et al. (1996) Vector-borne diseases and the basic reproduction number: a case study of African horse sickness. Med Vet Entomol 10: 19-28.    

21. Sertsou G, Wilson N, Baker M, et al. (2006) Key transmission parameters of an institutional outbreak during the 1918 influenza pandemic estimated by mathematical modelling. Theor Biol Med Model Nov 30: 38.

22. Heesterbeek JA (2002) A brief history of R0 and a recipe for its calculation. Acta biotheoretica 50: 189-204.    

23. Romulus Breban RV, Sally Blower (2007) Theory versus Data: How to Calculate R0? PLoS ONE 2: e282.    

24. Belongia EA, Sundaram ME, McClure DL, et al. (2015) Waning vaccine protection against influenza A (H3N2) illness in children and older adults during a single season. Vaccine 33: 246-251.    

25. Castilla J, Martinez-Baz I, Martinez-Artola V, et al. (2013) Decline in influenza vaccine effectiveness with time after vaccination, Navarre, Spain, season 2011/12. Euro Surveill 18: pii: 20388.

26. Kissling E, Valenciano M, Larrauri A, et al. (2013) Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study. Euro Surveill 18: pii: 20390.

27. Pebody R, Andrews N, McMenamin J, et al. (2013) Vaccine effectiveness of 2011/12 trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: evidence of waning intra-seasonal protection. Euro Surveill 18: pii: 20389.

28. Del Valle S, Hyman JM, Hethcote HW, et al. (2007) Mixing Patterns Between Age Groups Using Social Networks. Social Networks 29: 539-554.    

29. Glasser J, Feng Z, Moylan A, et al. (2012) Mixing in age-structured population models of infectious diseases. Math Biosci 235: 1-7.    

30. Del Valle SY, Hyman JM, Chitnis N (2013) Mathematical Models of Contact Patterns Between Age Groups for Predicting the Spread of Infectious Diseases. Math Biosci Eng 10: 1475-1497.    

31. Hethcote HW (2000) The Mathematics of Infectious Diseases. SIAM Rev 42: 599-653.    

Copyright Info: © 2017, Kasia A. Pawelek, et al., licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution Licese (http://creativecommons.org/licenses/by/4.0)

Download full text in PDF

Export Citation

Article outline

Show full outline
Copyright © AIMS Press All Rights Reserved